about
Clinical and virological efficacy of etravirine plus two active Nucleos(t)ide analogs in an heterogeneous HIV-infected populationPrognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohortFactors related to NT-proBNP levels in HIV patients aged over 40 years.Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.Splenic abscess due to Brucella infection: is the splenectomy necessary? Case report and literature review.Reconstitution Inflammatory Syndrome Like Reactive Hemophagocytic Syndrome Associated with Disseminated Histoplasmosis in a HIV Patient.Left ventricular mass in HIV-infected patients.[Male with fever and cutaneous lesions].[Effectiveness of human papillomavirus genotyping for detection of high-grade anal intraepithelial neoplasia compared to anal cytology].Influence of early surgical treatment on the prognosis of left-sided infective endocarditis: a multicenter cohort study.Durability of the first antiretroviral treatment regimen and reasons for change in patients with HIV infection.Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study.Screening for pandemic (H1N1) 2009 virus among hospital staff, Spain.[Enterococcal endocarditis: a multicenter study of 76 cases].HIV infection in the era of highly active antiretroviral therapy: the Malaga Study.Liver involvement in HIV-infected patients with early syphilis.[Clinical status, adherence to HAART and quality of life in HIV-infected patients receiving antiretroviral treatment].[Results of an early intervention program for patients with bacteremia discharged from the Emergency Department].Long-term assessment of didanosine, lamivudine, and efavirenz in antiretroviral-naive patients: 3-year follow-up.[Left-sided endocarditis due to gram-negative bacilli: epidemiology and clinical characteristics].A pragmatic approach for mortality prediction after surgery in infective endocarditis: Optimizing and refining EuroSCORE.The impact of an antimicrobial stewardship programme on the use of antimicrobials and the evolution of drug resistance.[Factors associated with an abnormal ankle-braquial index in a cohort of patients with HIV-1 infection].Colonic leishmaniasis in a patient with HIV: a case report.Raltegravir en pacientes con infección por el virus de la inmunodeficiencia humana y alto riesgo vascularAnkle-branch index and HIV: the role of antiretroviralsImpacto de los factores demográficos y psicosociales en la no adherencia a los fármacos antirretroviralesExperience of Using an App in HIV Patients Older Than 60 Years: Pilot Program[Immune reconstitution in HIV-infected patients. A prospective analysis][Lung nodules in a patient with human inmmunodeficiency virus infection][First antiretroviral therapy regimen in HIV-infected patients. Durability and factors associated with therapy changes][Manifestations of sarcoidosis in the upper respiratory tract][Avascular necrosis of the hip in a patient with HIV infection]Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: the VESD study[Endocarditis caused by extended spectrum beta lactamase producing Klebsiella][Protective role of antiretroviral treatment in the impairment of renal function in a cohort of human immunodeficiency virus patients][Upper digestive bleeding in homosexual male with human immunodeficiency virus infection][Streptococcus agalactiae induced cavitated pneumonia]Streptococcus agalactiae left-sided infective endocarditis. Analysis of 27 cases from a multicentric cohortSurgical treatment for infective endocarditis in elderly patients
P50
Q28538921-8049D776-B2AB-4176-94D4-7673A3BCA364Q33526060-09013A76-0966-4B65-B1E1-566517C7BCB7Q35589294-97B246F1-8C0B-4802-BC53-8D8F52145765Q36543845-CF3D6E45-F35F-473A-8834-027397C80956Q36799942-669D996E-D32D-4965-B2B7-6C6148EA7434Q39320467-F93F898F-386B-46E6-94BC-7D893B18A96AQ40359844-A74ECCAA-C5B7-455B-A432-18E043C2382AQ40515225-3E1C776F-6CC2-432F-B9CF-945A25D3E37AQ40755787-602ED216-0111-482C-B096-3DAD89BE4BE9Q41758998-BA019C45-4E1F-4397-B43A-AFCADC7EB926Q42228869-78EA1ED9-EA55-4471-95E1-CDB5194323B5Q42264003-79502C9C-8B67-4445-92FC-7D6DE1B0B2F5Q43180504-7002A455-113D-474B-94BC-D6E030CC7132Q43576953-9501521A-51FE-4CD1-8799-4DA14D069484Q44554477-89C5BF4D-24BE-4F02-A39D-6E564BD5AF38Q44937010-F9FF04CA-8B64-4556-836F-824FCCB277F1Q45182348-D4B29F23-DC2E-4271-A283-DBFC17212340Q45237703-7BD75178-2847-484D-9DE7-CA6FC307C2A5Q46753489-CDF2133B-BD6A-4371-BC81-F6241584CA5AQ50043501-47BC893E-3739-4AD6-BB71-B40461048232Q50167807-396E4AFD-194F-4021-B885-79A101E893F3Q51253360-E570A37E-39DD-448A-9F25-12AE9914E928Q52397939-2D592188-BFE1-43C2-B053-AA44CFB5E0E4Q54657247-11443B02-4F3D-4F43-A5F3-FCAC0C551863Q58889042-CE027A16-AB60-4589-91C7-E00F1E6BE3A4Q58889047-4E713BE7-D65F-4965-8CB7-943FF00F1C4CQ59617513-270F3594-07BD-4B78-A9AB-EF1F81EF9C02Q64057687-02D12DFB-FDA4-4320-9D04-83EB5A60CE2BQ80303765-FED5CFF1-19C8-4C09-B0B1-EF89216680FAQ80393949-388649C4-40E8-4C89-B831-04346E204E33Q82239041-F682A5F3-A1D0-48EA-88AB-CA21BB59809DQ82777373-CFA3ADE7-CD27-4BAD-90C6-1D7A72029A83Q82789150-CF2E835B-F2F1-4155-985B-A774B82D752CQ82976654-D93AF28B-C2B0-4E72-8D10-DC9A293184E4Q83582662-7DEC14F7-0CB0-4980-AB46-4E04C38CF26BQ83597590-E9196C06-CD44-4A83-8676-DFB2ACCEEB91Q83868544-86919394-0F64-41FB-8C6F-1B4D87576DDFQ83948161-28521038-F31C-474B-8840-F09E0D8E17AFQ84106588-0332921F-D386-424D-8413-CEFC363E31AAQ84378053-59FB1267-4F32-49C6-A28B-46C81ED67CFE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Javier de la Torre-Lima
@ast
Javier de la Torre-Lima
@en
Javier de la Torre-Lima
@es
Javier de la Torre-Lima
@nl
type
label
Javier de la Torre-Lima
@ast
Javier de la Torre-Lima
@en
Javier de la Torre-Lima
@es
Javier de la Torre-Lima
@nl
prefLabel
Javier de la Torre-Lima
@ast
Javier de la Torre-Lima
@en
Javier de la Torre-Lima
@es
Javier de la Torre-Lima
@nl
P106
P1153
8860522200
P21
P31
P496
0000-0003-4718-0320